Comparison of 3, 5 and 7 days' treatment with Quinimax for falciparum malaria in Guinea-Bissau

Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):462-4. doi: 10.1016/s0035-9203(97)90286-8.

Abstract

For treatment of malaria, the World Health Organization recommends 10 mg of quinine per kg body-weight 3 times a day for at least 7 d. In Guinea-Bissau, as in several other African countries, a 3 d treatment regimen (10 mg/kg twice daily) is currently used. We therefore compared the 3 d treatment period with periods of 5 and 7 d. A total of 145 children with clinical malaria due to monoinfection with Plasmodium falciparum, with > or = 20 parasites per 200 leucocytes, were treated with intramuscular Quinimax 10 mg per kg body-weight twice daily for 3, 5 or 7 d. The children were then examined once weekly for 4 weeks. Following the 3 d treatment regimen, 34 of 43 children (79%) had parasitaemia on day 28 or before; following the 5 d treatment regimen, 36 of 40 children (90%) did so; and following the 7 d treatment regimen, 7 of 62 children (11%) were parasitaemic at that time. This study thus suggests that the currently recommended 3 d Quinimax treatment regimen in Guinea-Bissau for moderate and severe malaria is not effective.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antimalarials / therapeutic use*
  • Child
  • Child, Preschool
  • Cinchona Alkaloids / administration & dosage
  • Drug Combinations
  • Female
  • Guinea-Bissau
  • Humans
  • Infant
  • Malaria, Falciparum / blood
  • Malaria, Falciparum / drug therapy*
  • Male
  • Quinidine / administration & dosage
  • Quinine / therapeutic use*
  • Time Factors

Substances

  • Antimalarials
  • Cinchona Alkaloids
  • Drug Combinations
  • Quinine
  • Quinidine
  • cinchonine